Literature DB >> 25092149

Polycystic kidney disease: Progression of polycystic kidney disease--a lack of progress?

Stephen McDonald1, Gopala Rangan2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25092149     DOI： 10.1038/nrneph.2014.138

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Therapy for polycystic kidney disease? It's water, stupid!

Authors:  Jared J Grantham
Journal:  J Am Soc Nephrol       Date:  2007-11-21       Impact factor: 10.121

2.  Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study.

Authors:  Christine Patch; Judith Charlton; Paul J Roderick; Martin C Gulliford
Journal:  Am J Kidney Dis       Date:  2011-04-02       Impact factor: 8.860

3.  Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease.

Authors:  Bjarne Orskov; Vibeke Rømming Sørensen; Bo Feldt-Rasmussen; Svend Strandgaard
Journal:  Nephrol Dial Transplant       Date:  2011-08-26       Impact factor: 5.992

4.  Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; J A Breyer; G J Beck; V W Dennis; J A Hartman; D Roth; T I Steinman; S R Wang; M E Yamamoto
Journal:  J Am Soc Nephrol       Date:  1995-06       Impact factor: 10.121

5.  Tolvaptan in patients with autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Arlene B Chapman; Olivier Devuyst; Ron T Gansevoort; Jared J Grantham; Eiji Higashihara; Ronald D Perrone; Holly B Krasa; John Ouyang; Frank S Czerwiec
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

6.  Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.

Authors:  John H Stewart; Margaret R E McCredie; Sheila M Williams; Stephen P McDonald
Journal:  Nephrology (Carlton)       Date:  2004-08       Impact factor: 2.506

7.  Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure.

Authors:  Catriona Shaw; Roslyn J Simms; David Pitcher; Richard Sandford
Journal:  Nephrol Dial Transplant       Date:  2014-04-15       Impact factor: 5.992

8.  Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.

Authors:  Edwin M Spithoven; Anneke Kramer; Esther Meijer; Bjarne Orskov; Christoph Wanner; Fergus Caskey; Frederic Collart; Patrik Finne; Damian G Fogarty; Jaap W Groothoff; Andries Hoitsma; Marie-Béatrice Nogier; Maurizio Postorino; Pietro Ravani; Oscar Zurriaga; Kitty J Jager; Ron T Gansevoort
Journal:  Kidney Int       Date:  2014-05-14       Impact factor: 10.612

9.  Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany.

Authors:  Hartmut P H Neumann; Cordula Jilg; Janina Bacher; Zinaida Nabulsi; Angelica Malinoc; Barbara Hummel; Michael M Hoffmann; Nadina Ortiz-Bruechle; Sven Glasker; Przemyslaw Pisarski; Hannes Neeff; Annette Krämer-Guth; Markus Cybulla; Martin Hornberger; Jochen Wilpert; Ludwig Funk; Jörg Baumert; Dietrich Paatz; Dieter Baumann; Markus Lahl; Helmut Felten; Martin Hausberg; Klaus Zerres; Charis Eng
Journal:  Nephrol Dial Transplant       Date:  2013-01-08       Impact factor: 5.992

10.  Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?

Authors:  Eiji Higashihara; Kikuo Nutahara; Mitsuhiro Tanbo; Hidehiko Hara; Isao Miyazaki; Kuninori Kobayashi; Toshiaki Nitatori
Journal:  Nephrol Dial Transplant       Date:  2014-04-15       Impact factor: 5.992
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.